Home
Cathay Drug

Cathay Drug Market Share Analysis for March 2026

Homepage

Health > Pharmacy

Domaincathaydrug.com

Year Founded1952

Employees201 - 500

Annual Revenue$25M - $50M

Cathay Drug

Cathay Drug (including company regionals)

cathaydrug.com

See more website traffic and engagement information

Cathay Drug Revenue up to March 2026 is 25M - 50M

revenue generated by Cathay Drug top domains

Cathay Drug top domains revenue over 3 years

Revenue for Cathay Drug top domains

cathaydrug.com25M - 50M

See more with Sales Intelligence

Total visits to Cathay Drug's top domains

Understand Cathay Drug market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

cathaydrug.com7.4K

See more with Sales Intelligence

Avg. visit duration in Cathay Drug's top domains

Analyze Cathay Drug engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

cathaydrug.com00:00:21

See more with Sales Intelligence

Avg. pageviews on Cathay Drug's top domains

See how Cathay Drug keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

cathaydrug.com1.61

See more with Sales Intelligence

Cathay Drug top competitors by domain

Top similar sites in March 2026, ranked by their affinity

stjosephdrug.comCompany NameSt. Joseph DrugEmployees501 - 1000HQPhilippines, DagupanAnnual revenue$5M - $10MTotal visits12.5KHealth > Pharmacy

Top technologies used by Cathay Drug

These are the website technologies, by industry, used by Cathay Drug top domains

Widget (7)

Twemoji

Social (3)

Instagram

Advertising (2)

DoubleClick

Mobile (2)

Meta Viewport

More Technologies

9

See all

News & Signals from Cathay Drug

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCathay Drug Company Inc. had issues with recall" of several batches of Triocef oral drops on Feb 5th '25.According to FDA Advisory No. 2025-0093 issued on Feb. 5, the Cathay Drug Company Inc. sought the "voluntary recall" of several batches of Triocef oral drops (generic name: Cefixime) because these "did not meet the required product specification based on the chemical assay tests performed by a third-party laboratory, which also concurred with the results of the manufacturer."